Patents Assigned to Ritter Pharmaceuticals, Inc.
-
Patent number: 11028422Abstract: The present invention describes a process for preparing ultrapure (?95%) galacto-oligosaccharides (GOS), starting from GOS at lower purities by using sequential microbiological purifications involving Saccharomyces cerevisiae and Streptococcus thermophilus.Type: GrantFiled: October 5, 2018Date of Patent: June 8, 2021Assignee: Ritter Pharmaceuticals, Inc.Inventors: Silvia Giacomelli, Marco Manoni, Giovanni Cipolletti, Silvia Biagiolini, Luana Vagnoli, Jacopo Chini
-
Patent number: 9808481Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.Type: GrantFiled: June 20, 2016Date of Patent: November 7, 2017Assignee: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Patent number: 9775860Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.Type: GrantFiled: September 9, 2015Date of Patent: October 3, 2017Assignee: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Patent number: 9592248Abstract: The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.Type: GrantFiled: September 21, 2015Date of Patent: March 14, 2017Assignee: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Patent number: 9579340Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.Type: GrantFiled: September 4, 2015Date of Patent: February 28, 2017Assignee: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Patent number: 9370532Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.Type: GrantFiled: September 12, 2014Date of Patent: June 21, 2016Assignee: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Patent number: 9226933Abstract: The invention provides methods and compositions for treating lactose intolerance. In embodiments, the invention provides methods and composition for decreasing symptoms of lactose intolerance by administering to an individual suffering from lactose intolerance increasing doses of lactose using a protocol such that at the end of treatment the individual's symptoms of lactose intolerance are decreased and such that symptoms remain decreased after a period of time.Type: GrantFiled: March 26, 2008Date of Patent: January 5, 2016Assignee: Ritter Pharmaceuticals, Inc.Inventor: Andrew J. Ritter
-
Patent number: 9200303Abstract: The present invention describes a process for preparing ultrapure (?95%) galacto-oligosaccharides (GOS), starting from GOS at lower purities by using sequential microbiological purifications involving Saccharomyces cerevisiae and Streptococcus thermophilics.Type: GrantFiled: August 6, 2010Date of Patent: December 1, 2015Assignee: Ritter Pharmaceuticals, Inc.Inventors: Silvia Giacomelli, Marco Manoni, Giovanni Cipolletti, Silvia Biagiolini, Luana Vagnoli, Jacopo Chini
-
Publication number: 20150118297Abstract: The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.Type: ApplicationFiled: June 2, 2014Publication date: April 30, 2015Applicant: RITTER PHARMACEUTICALS, INC.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Publication number: 20140234407Abstract: The method for increasing lactose tolerance in subjects exhibiting lactose intolerance symptoms implements a protocol where the subjects ingest a gradually increasing amount of lactose containing product over a six week period. At various points during the six week period the subject ingests the lactose containing product once a day and then twice a day. The lactose containing product can be in liquid form, such as for example, milk, and is preferably in a powder form which is taken either by ingesting capsules having the lactose powder or in a granular form mixed with water or other non-lactose containing liquid. At the end of the six week period, the subject's tolerance for lactose containing products is substantially increased, with the potential of eliminating the subject's lactose intolerant behavior indefinitely.Type: ApplicationFiled: October 24, 2013Publication date: August 21, 2014Applicant: RITTER PHARMACEUTICALS, INC.Inventor: Andrew Ritter
-
Patent number: 8785160Abstract: The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.Type: GrantFiled: April 28, 2011Date of Patent: July 22, 2014Assignee: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Publication number: 20130316972Abstract: The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes. The invention also provides diagnostic instruments and methods of diagnosing lactose intolerance using the diagnostic instruments.Type: ApplicationFiled: January 17, 2013Publication date: November 28, 2013Applicant: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, Kristina A. Fitzgerald, Marilyn R. Carlson
-
Publication number: 20130244969Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.Type: ApplicationFiled: March 4, 2013Publication date: September 19, 2013Applicant: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Patent number: 8492124Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.Type: GrantFiled: February 17, 2010Date of Patent: July 23, 2013Assignee: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Robert Klaenhammer
-
Patent number: 8486668Abstract: The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.Type: GrantFiled: August 4, 2011Date of Patent: July 16, 2013Assignee: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Publication number: 20130177612Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.Type: ApplicationFiled: March 4, 2013Publication date: July 11, 2013Applicant: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Publication number: 20130165407Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.Type: ApplicationFiled: February 19, 2013Publication date: June 27, 2013Applicant: RITTER PHARMACEUTICALS, INC.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Publication number: 20130034601Abstract: The method for increasing lactose tolerance in subjects exhibiting lactose intolerance symptoms implements a protocol where the subjects ingest a gradually increasing amount of lactose containing product over a six week period. At various points during the six week period the subject ingests the lactose containing product once a day and then twice a day. The lactose containing product can be in liquid form, such as for example, milk, and is preferably in a powder form which is taken either by ingesting capsules having the lactose powder or in a granular form mixed with water or other non-lactose containing liquid. At the end of the six week period, the subject's tolerance for lactose containing products is substantially increased, with the potential of eliminating the subject's lactose intolerant behavior indefinitely.Type: ApplicationFiled: September 28, 2012Publication date: February 7, 2013Applicant: RITTER PHARMACEUTICALS, INC.Inventor: Andrew J. Ritter
-
Publication number: 20110287072Abstract: The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.Type: ApplicationFiled: August 4, 2011Publication date: November 24, 2011Applicant: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Publication number: 20110236480Abstract: The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.Type: ApplicationFiled: April 28, 2011Publication date: September 29, 2011Applicant: RITTER PHARMACEUTICALS, INC.Inventors: Andrew J. RITTER, Dennis SAVAIANO, David BARNES, Todd KLAENHAMMER